A new COL1A1 mutation in a Greek patient with osteogenesis imperfecta: Response to a low-dose protocol of zoledronic acid and two-year follow-up

Autor:	Michail Sarantis, Artemis Doulgeraki, Yolanda Gyftodimou, Panagoula Kollia, Evdoxia Mpourazani, Stavroula Samara, Helen Athanasopoulou, Dimitra Lianou
Rok vydání:	2018
Předmět:	Oncology medicine.medical_specialty Zoledronic acid business.industry Osteogenesis imperfecta Internal medicine Low dose Mutation (genetic algorithm) medicine business medicine.disease medicine.drug
Zdroj:	Journal of Research and Practice on the Musculoskeletal System. :75-80
ISSN:	2585-2787
DOI:	10.22540/jrpms-02-075
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::0a4f1bca004e0980524333049bb84558 https://doi.org/10.22540/jrpms-02-075 Zobrazit plný text záznamu